Procedure guideline for breast scintigraphy

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1233-1235

  Davis, Marie ^a   Khalkhali, Iraj ^b   Diggles, Linda E ^b   Taillefer, Raymond ^b   Vandestreek, Penny R ^b   Peller, Patrick J ^b   Abdel Nabi, Hani H ^b  

^a Society of Nuclear Medicine   (United States)

^b NONE

Author keywords

Breast scintigraphy; Procedure guideline

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

BREAST CANCER; CANCER DIAGNOSIS; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCINTIMAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT INDICATION;

EID: 0344242090     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Cutrone JA, Shane Yospur L, Khalkhali I, et al. Immunohistologic assessment of Tc-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med. 1998;39:449-453.
2. Del Vecchio S, Ciarmiello A, Pace L, et al. Fractional retention of technetium-99m-sestamibi as an index of p-glycoprotein expression in untreated breast cancer patients. J Nucl Med. 1997;38:1348-1351.
3. Diggles L, Mena I, Khalkhali I. Technical aspects of prone dependent-breast scintimammography. J Nucl Med Tech. 1994;22:165-170.
4. International Commission on Radiological Protection. Radiological Protection in Biomedical Research. ICRP publication 62. Stockholm, Sweden: ICRP; 1992.
5. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg. 1994;178:491-497.
6. Palmedo H, Schomburg A, Grunwald F, et al. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Nucl Med Biol. 1996;23:681-684.
7. Peller PJ, Khedkar NY, Martinez CJ. Breast tumor scintigraphy. J Nucl Med Tech. 1996;24:198-203.
8. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriḡre. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995;36: 1758-1765.
9. Tiling R, Sommer H, Pechmann M, et al. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med. 1997;38:58-62.
10. Villanueva-Meyer J, Leonard MH Jr, Briscoe E, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med. 1996;37:926-930.